Source: Eur Respir J, 59 (1) 2100160; 10.1183/13993003.00160-2021



Rating:

Share or cite this content

Citations should be made in the following way:
P. Jane McDowell, John H. Stone, Yuqing Zhang, Kirsty Honeyford, Louise Dunn, R. Jayne Logan, Lorcan P.A. McGarvey, Claire A. Butler, Liam G. Heaney. Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index. Eur Respir J, 59 (1) 2100160; 10.1183/13993003.00160-2021

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of the steroid sparing effects of Mepolizumab using the Glucocorticoid Toxicity Index Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma Source: International Congress 2018 – Asthma analysis Year: 2018 Evaluation of Airway Wall Thickness in Severe Asthma with monoclonal antibody therapy Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Curcumin as an Add-on Therapy of Moderate Partially Controlled Asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Long-Term Remission and Changes in the Severity of Asthma over 30 Years–  TRAIL Cohort Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis Source: International Congress 2018 – COPD management Year: 2018 Cytokine-induced glucocorticoid resistance: Effect on GILZ expression and reversal by formoterol Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Chronic Cough is associated with higher levels of Systemic Immune Inflammation Index Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Preventive and therapeutic treatment with a7 nicotinic receptor agonist reduced lung inflammation and collagen deposition in mice with acute lung injury Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Erythromycin Reverses Nets-induced Corticosteroid Insensitivity By Inhibition Of The Pi3kd/akt Pathway Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 The Effect of Lipid Profile and Obesity on the Grade of Neutropenia in Patients with Small Cell Lung Cancer Treated with Etoposide-Cisplatin as First Regimen. Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Simulating the Beneficial Effects of Aerobic Exercise in Asthma in vitro: a way to Understand the Cellular Effects of Exercise in Asthma – Involvement of STAT6 Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Clinically Meaningful Improvement in Total Rhinoconjunctivitis Score with Olopatadine/mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021